United States· US:50419-475_440713bb-71c2-4ed9-b3d6-e2c138f088d0

LYNKUET

A elinzanetant product containing elinzanetant, registered in United States by Bayer HealthCare Pharmaceuticals Inc.. The same ATC class is registered in 10 of our 19 countries.

ATC G02CX07US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedLYNKUETATCG02CX07REGISTER NO.US:50419-475_440713bb…PACKS LISTED6CHECKEDAugust 2, 2026

Where it is registered

Elinzanetant is registered in 10 of 19 countries.

Countries holding a registration under ATC G02CX07 (elinzanetant), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 6 of them publish a price we can compare per daily dose

Elinzanetant · ATC G02CX07

10 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
ELINZANETANT
Manufacturer
Bayer HealthCare Pharmaceuticals Inc.
Country
United States (US)
ATC code
G02CX07
ATC class
Elinzanetant
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
August 2, 2026

Packs & prices · 6

  • ndc11
    50419-475-05
  • ndc11
    50419-475-72
  • ndc11
    50419-475-73
  • ndc11
    5041947505
    5 BLISTER PACK in 1 CARTON (50419-475-05) / 12 CAPSULE in 1 BLISTER PACK (50419-475-01)
  • ndc11
    5041947572
    2 BLISTER PACK in 1 CARTON (50419-475-72) / 12 CAPSULE in 1 BLISTER PACK (50419-475-71)
  • ndc11
    5041947573
    1 BLISTER PACK in 1 CARTON (50419-475-73) / 12 CAPSULE in 1 BLISTER PACK (50419-475-71)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Elinzanetant in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All elinzanetant products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Lynkuet
  • Liechtenstein · Lynkuet
  • Norway · Lynkuet

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c958da8d-dd9c-4e08-b9e6-9ec9a4d06be0
GET /v1/drugs/c958da8d-dd9c-4e08-b9e6-9ec9a4d06be0?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "60",
  "substance": "ELINZANETANT",
  "productndc": "50419-475",
  "dosage_form": "CAPSULE",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "NDA219469",
  "marketing_category": "NDA"
}

See everything about elinzanetant.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.